Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4603842 | 0.93 | KLK7 (0.30) | KLK7KLK5 | |
| SCHEMBL4189082 | 0.90 | KLK7 (0.31) | KLK7KLK5 | |
| SCHEMBL4189088 | 0.90 | KLK7 (0.31) | KLK7KLK5 | |
| SCHEMBL4189084 | 0.90 | KLK7 (0.31) | KLK7KLK5 | |
| SCHEMBL4174926 | 0.89 | KLK7 (0.30) | KLK7KLK5 | |
| SCHEMBL4183449 | 0.84 | KLK7 (0.31) | KLK7KLK5 | |
| SCHEMBL4179073 | 0.84 | KLK7 (0.31) | KLK7KLK5 | |
| SCHEMBL4183453 | 0.84 | KLK7 (0.31) | KLK7KLK5 | |
| SCHEMBL4183454 | 0.84 | KLK7 (0.31) | KLK7KLK5 | |
| SCHEMBL4185494 | 0.83 | CYP2D6 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090186868-A1 | Taxane Compound Having Azetidine Ring Structure | DAIICHI SANKYO COMPANY LIMITED (JP) | 2009-07-23 | — | — | US | disclosed |
| US-20090186868-A1 | Taxane Compound Having Azetidine Ring Structure | DAIICHI SANKYO COMPANY LIMITED (JP) | 2009-07-23 | — | — | US | disclosed |
| EP-1942109-A1 | TAXANE COMPOUND WITH AZETIDINE RING STRUCTURE | Daiichi Sankyo Company, Limited (JP) | 2008-07-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090186868-A1 | Taxane Compound Having Azetidine Ring Structure | ABCC1, AZI2, TPD52L2 | KLK7 3535/4885KLK5 2856/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.